Search This Blog

Tuesday, August 4, 2026

Acadia Pharma ups guidance

 

Acadia Pharmaceuticals reports Q2 2026 revenue of $308 million (+16% YoY), raises full-year 2026 revenue guidance to $1.24–$1.30 billion

  • Company also raises full-year 2026 DAYBUE sales guidance, alongside higher total revenue outlook.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)